Blastic NK cell lymphoma: Difference between revisions
Jump to navigation
Jump to search
m Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Infobox Disease | {{Infobox Disease | ||
| Name = {{PAGENAME}} | | Name = {{PAGENAME}} | ||
| Line 14: | Line 15: | ||
}} | }} | ||
{{SI}} | {{SI}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
| Line 30: | Line 28: | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{Lymphoid malignancy}} | {{Lymphoid malignancy}} | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
Revision as of 17:45, 12 September 2012
| Blastic NK cell lymphoma | |
| ICD-O: | 9727/3 |
|---|---|
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Blastic NK cell lymphoma is a type of lymphoma.
Pathophysiology
It does not appear to be associated with Epstein Barr virus.[1]
Diagnosis
Cells are positive for CD4 and CD56.[2][3]
References
- ↑ Chan JK, Sin VC, Wong KF; et al. (1997). "Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm". Blood. 89 (12): 4501–13. PMID 9192774. Unknown parameter
|month=ignored (help) - ↑ Ng AP, Lade S, Rutherford T, McCormack C, Prince HM, Westerman DA (2006). "Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a report of five cases". Haematologica. 91 (1): 143–4. PMID 16434387. Unknown parameter
|month=ignored (help) - ↑ Kim Y, Kang MS, Kim CW, Sung R, Ko YH (2005). "CD4+CD56+ lineage negative hematopoietic neoplasm: so called blastic NK cell lymphoma". J. Korean Med. Sci. 20 (2): 319–24. PMID 15832009. Unknown parameter
|month=ignored (help)